BioNxt Solutions (BNXT.CN) Stock Price

BioNxt Solutions Price

CSE·CLOSED
0.25
​
Market closed

Revenue at BioNxt Solutions has contracted by 47.1% per year over the past 4 years to 26,985.00 CAD. BioNxt Solutions's net margin stands at -19,683.2%, down from -4,885.7% several years earlier.

BioNxt Solutions stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioNxt Solutions business model & stock analysis

BioNxt Solutions, Inc. engages in the business of producing, extracting, and selling medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets. The Company, through its subsidiary, 3a-diagnostics GmbH, offers diagnostic products, which include COVID-19 PCR Diagnostic Kit and Peri-Implantitis Oral Biosensor.

Frequently asked questions about BioNxt Solutions

Converted at the current exchange rate, the BioNxt Solutions share trades at 0.16 EUR (0.25 CAD).

The BioNxt Solutions share (BNXT.CN) is listed on 4 stock exchanges, including: XETRA (BXT.DE), Frankfurt (BXT.F), München (BXT.MU).

The revenue cannot currently be calculated for BioNxt Solutions.

The profit cannot currently be calculated for BioNxt Solutions.

The P/E ratio cannot be calculated for BioNxt Solutions at the moment.

The P/S cannot be calculated for BioNxt Solutions currently.

The Eulerpool Quality Score for BioNxt Solutions is 4/10.

The ISIN of BioNxt Solutions is CA0909741062. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of BioNxt Solutions is A3D1K3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of BioNxt Solutions is BNXT.CN. The ticker symbol is used to trade BioNxt Solutions shares on the stock exchange.

Fair ValueTerminal
0.21 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bionxt.com
Country
Currency
CAD
Initial public offering
Aug 6, 2019
ISIN
CA0909741062
Cusip
090974106
Market capitalization
30.62 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
18.35
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
130.51 %
Last updated Nov 16, 2026, 3:45 AM

BioNxt Solutions Peer Group

BioNxt Solutions Ticker

CNQ · BNXT.CNFRANKFURT · BXT.FMUNICH · BXT.MUXETRA · BXT.DE

BioNxt Solutions FIGI

BNXT:CN · BBG00PVP57Y6BNXT:CF · BBG00PVP5847BNXT:TG · BBG00PVP58D7BNXT:TW · BBG00PVP58G4BNXT:DG · BBG00PVP58N6BNXT:QF · BBG00PVP58P4BNXT:QH · BBG00PVP58Q3BNXT:TO · BBG00PVP58T0BNXT:DL · BBG00PVP58V7BNXT:DM · BBG00PVP58W6BNXT:DN · BBG00PVP58X5BNXT:QG · BBG00PVP58Y4

All fundamentals and in-depth analysis of BioNxt Solutions

Our stock analysis for BioNxt Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioNxt Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.